Daan Gene Co., Ltd. (SHE:002030)
China · Delayed Price · Currency is CNY 6.33
+0.02 (0.32%)
Jan 23, 2026, 11:30 AM CST
Daan Gene Market Cap
Daan Gene has a market cap or net worth of 8.86 billion as of January 22, 2026. Its market cap has increased by 7.86% in one year.
Market Cap
8.86B
Enterprise Value
8.33B
Revenue
765.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.33
Market Cap Chart
Since August 9, 2004, Daan Gene's market cap has increased from 1.30B to 8.86B, an increase of 580.35%. That is a compound annual growth rate of 9.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 8.86B | 5.87% |
| Dec 31, 2025 | 8.36B | 4.93% |
| Dec 31, 2024 | 7.97B | -41.32% |
| Dec 29, 2023 | 13.59B | -37.79% |
| Dec 30, 2022 | 21.84B | -22.43% |
| Dec 31, 2021 | 28.15B | -6.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acrobiosystems | 10.12B |
| Chengzhi | 10.11B |
| Chengdu Kanghua Biological Products | 9.78B |
| Jiangxi Fushine Pharmaceutical | 9.36B |
| Anhui Huaheng Biotechnology | 9.32B |
| Sino Biological,Inc. | 9.30B |
| Jiangsu Aidea Pharmaceutical Group | 9.05B |
| Nanjing Vazyme Biotech | 8.51B |